Compounders’ Policy Shift Creates Opportunity For Broad Legislative Proposal
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate HELP Committee hopes to have a bipartisan bill on tighter compounder regulation ready in late spring; House Energy and Commerce Committee remains focused on investigating what went wrong in FDA’s oversight of the New England Compounding Center.